New, early-stage research suggest that B16172 does have some ability to escape the effects of vaccines.
The increased infectiousness of B16172 could magnify the impact of vaccines being less effective against it.
Surge vaccination is being used to combat the B16172 variant, while the government prepares for a vaccine booster programme.
A viral immunologist answers key questions about the B16172 variant.
The B16172 variant of concern risks spreading in the UK when restrictions on indoor socialising ease on May 17.
There’s still a lot we don’t know about the latest variant of concern: B16172.